Labixiaoxin Snacks Completes Acquisition and Issues Shares, Convertible Bond

Labixiaoxin Snacks Group Ltd. ( (HK:1262) ) has issued an announcement.

Labixiaoxin Snacks Group Limited has completed a previously announced discloseable transaction involving the acquisition of a target company, using newly issued consideration shares and a convertible bond under its general mandate. All conditions under the sale and purchase agreement were fulfilled, and the deal closed on 31 March 2026, aligning with the group’s broader strategy of expanding its footprint in the snack food sector.

Following completion, the target company has become a wholly owned subsidiary of Labixiaoxin Snacks Group and its financial results will be fully consolidated into the group’s accounts. The move is expected to strengthen the company’s operational scale and financial profile, potentially enhancing its competitive position in the regional snacks market and affecting returns for shareholders as the acquired business is integrated.

The most recent analyst rating on (HK:1262) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Labixiaoxin Snacks Group Ltd. stock, see the HK:1262 Stock Forecast page.

More about Labixiaoxin Snacks Group Ltd.

Labixiaoxin Snacks Group Limited is a Bermuda-incorporated company listed in Hong Kong that operates in the snack foods sector. The group focuses on producing and selling leisure snack products, targeting mass-market consumers in mainland China and surrounding markets through its portfolio of branded packaged foods and related offerings.

The company leverages its public listing on the Stock Exchange of Hong Kong to fund expansion and strategic investments. Its board comprises executive, non-executive and independent non-executive directors, reflecting a standard governance structure for mid-sized consumer companies in the region and supporting its growth and acquisition strategy.

Average Trading Volume: 161,105

Technical Sentiment Signal: Buy

Current Market Cap: HK$860.6M

See more insights into 1262 stock on TipRanks’ Stock Analysis page.